ORIC — Oric Pharmaceuticals Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates ORIC Bullish with a Setup Score of 43, net conviction 40, actionability 46. How the Setup Score works →

Total Setup Score43
Directional BiasBullish
Net Conviction40
Actionability46 (in range)

Key signals behind this score

About Oric Pharmaceuticals Inc

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates include enozertinib formerly known as ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 an… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$10.85
Market Cap$1.13B
Float82.7M
Shares Outstanding103.5M
vs. Analyst Target+87.0% to analyst PT
Dividend RateNone
Analyst Target Price$20.29 (12 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$73.7M -$970,000 -$48.4M
2021 N/A -$77.7M -$897,000 -$78.0M
2022 N/A -$89.1M -$966,000 -$85.8M
2023 N/A -$101M -$1.0M -$99.7M
2024 N/A -$128M -$1.1M -$127M
2025 N/A -$129M -$1.2M -$128M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$36.4M
Sep 2025 N/A -$32.6M
Dec 2025 N/A -$30.5M
Mar 2026 N/A -$35.8M

Ownership & Float

Insider Ownership5.8%
Institutional Ownership114.2%
Short Float25.5%
% of All Funds Holding1.98%
Number of Funds Holding163

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$9.00Near-term / short-term trend
Weekly40-Week SMA$10.57Medium-term trend
Weekly80-Week SMA$9.64Cyclical trend (business cycle)
Weekly200-Week SMA$8.46Secular trend (multi-year)
Monthly10-Month SMA$10.96Near-term monthly trend
Monthly20-Month SMA$9.90Medium-term monthly trend
Monthly40-Month SMA$9.41Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$8.50 support 1.27x 0 months ago
$8.30 support 1.37x 5 months ago
$5.70 support 2.09x 13 months ago

Historical Earnings Reactions (25 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 1.19% 0.85% 60.00% 9.17% -2.87%
1 Day 2.84% 1.47% 72.00% 14.60% -11.58%
1 Week 5.69% 5.73% 56.00% 43.85% -18.00%
2 Weeks 6.82% 4.73% 60.00% 50.00% -25.42%
1 Month 9.20% 4.81% 58.33% 63.51% -39.15%

Next earnings: August 11, 2026 (31 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.34% 46.4% 291
Tuesday 0.16% 44.4% 322
Wednesday -0.38% 46.6% 320
Thursday 0.10% 48.1% 312
Friday 0.28% 46.8% 310

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 114.2%

Insider Transactions — Smart Summary

Total insider ownership: 5.8%

12-Month Insider Activity Summary

Total Filings10
Net Value-$3.9M
Net Shares Change-169,482
% of Float-0.2%
C-Suite Filings8
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Chacko Jacob PRESIDENT AND CEO -$3.2M 4 N/A
Piscitelli Dominic Chief Financial Officer -$684,852.788 3 N/A
Multani Pratik S Chief Medical Officer -$97,128.56 1 N/A
Heyman Richard A. -$84,030.82 2 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-12-17 – 2025-12-17 3 3 -$496,624.488 3 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-10-02 Chacko Jacob PRESIDENT AND CEO -$1.1M Transaction at $12.04, now -9.8%
2025-09-24 Chacko Jacob PRESIDENT AND CEO -$1.3M Transaction at $10.80, now +0.5%
2025-12-17 Piscitelli Dominic Chief Financial Officer -$97,127.488 Transaction at $9.06, now +19.8%
2025-12-17 Multani Pratik S Chief Medical Officer -$97,128.56 Transaction at $9.06, now +19.8%
2025-12-17 Chacko Jacob PRESIDENT AND CEO -$302,368.44 Transaction at $9.06, now +19.8%
2025-10-08 Chacko Jacob PRESIDENT AND CEO -$461,519.52 Transaction at $12.32, now -11.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Oric Pharmaceuticals Inc (ORIC) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ORIC on Trend Edge →